mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |